New treatment option for Labor Induction
Official title Effect of Dexamethasone on Labour Induction in Term Pregnancies
ClinicalTrials.gov ID: NCT07109258
What this study is testing
What is Dexamethasone (Decadron) 8mg IM injection?
Dexamethasone (Decadron) 8mg IM injection is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for labor induction.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of the study is to assess the effect of dexamethasone on labour induction in term pregnancies. Primary outcome: The interval between initiation of induction and beginning of the active phase of labour.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Age \> 18 years.
- Nulliparous.
- Vertex presentation.
- Singleton pregnancy.
- Gestational age ≥ 39 weeks according to a reliable date for the last menstrual period or a first-trimester ultrasound evaluation.
You likely can't join if
- Indication for cesarean section e. g. Placenta previa, intrauterine growth retardation, non-vertex presentation and previous cesarean section.
- Maternal medical disorders as diabetes mellitus and severe pre-eclampsia.
- Preterm labour and preterm rupture of membranes.
- Gestational age \<39 weeks of gestation.
- Fetal macrosomia \> 4kg (estimated by u/s).
See the full eligibility criteria
- Age \> 18 years.
- Nulliparous.
- Vertex presentation.
- Singleton pregnancy.
- Gestational age ≥ 39 weeks according to a reliable date for the last menstrual period or a first-trimester ultrasound evaluation.
- No contraindication for vaginal delivery.
- Indication for cesarean section e. g. Placenta previa, intrauterine growth retardation, non-vertex presentation and previous cesarean section.
- Maternal medical disorders as diabetes mellitus and severe pre-eclampsia.
- Preterm labour and preterm rupture of membranes.
- Gestational age \<39 weeks of gestation.
- Fetal macrosomia \> 4kg (estimated by u/s).
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Manial, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Manial, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.